# FDA Warning Letter: Re-Gen Active Lab, Inc.
> 2022-06-28 · Office of Biological Products Operations – Division 2 · `42a0692e37458cd3`
## Letter
- **Company:** Re-Gen Active Lab, Inc.
- **Posted Date:** 2022-06-28
- **Letter Issue Date:** 2022-05-27
- **Issuing Office:** Office of Biological Products Operations – Division 2
## Subject
Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*